PRICE T ROWE ASSOCIATES INC /MD/

Position in AKTS — Aktis Oncology, Inc.

CIK 80255 BALTIMORE, MD

Position in AKTS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$24,607,572

-$3,375,894 QoQ

Shares Held

763,499

-51.2% QoQ

Ownership

1.37%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 114 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. AKTS ranks #89 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,607,572	763,499	-51.2%	Shares	Sole	2026-08-14
2026-03-31	$27,983,466	1,564,196	—	Shares	Defined	2026-05-15
No filing history on record for this holder in this stock.